The Cardiometabolic Disease Market is being driven by the rising prevalence of obesity and metabolic disorders worldwide. Changes in dietary patterns, sedentary lifestyles, and population aging are contributing to a broader patient population requiring long-term disease management. The cardiometabolic disease market is expected to reach US$ 155.56 billion by 2034 from US$ 109.28 billion in...